All Updates

Un nuevo informe (en inglés) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) descubrió que más del 70% de los pacientes con seguro comercial tuvieron gastos de bolsillo para pruebas de diagnóstico de seguimiento del cáncer de mama en 2023.

Un nuevo informe (en inglés) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) descubrió que más del 70% de los pacientes con seguro comercial tuvieron gastos de bolsillo para pruebas de diagnóstico de seguimiento del cáncer de mama en 2023.

El viernes pasado, la Corte Suprema de Estados Unidos anunció su decisión de conceder la petición del gobierno para la revisión del caso (certiorari) en el caso Braidwood Management versus Becerra. El aspecto principal de este caso se encuentra en el requisito bajo la Ley del Cuidado de Salud a

HELENA, Montana – Residents from across the state will rally at noon on Wednesday at the Capitol Flag Plaza to send a clear and urgent message to lawmakers: It is time to remove the sunset clause from Montana Medicaid expansion. Nearly 80,000 Montanans are enrolled in Montana's current adult Medicaid

OLYMPIA, Wash. -- As Washington legislators convene today for a new session, American Cancer Society Cancer Action Network advocates will ask them to prioritize patients' ready access to needed and proven biomarker testing. Biomarker testing is about identifying the most effective treatment for patients with cancer and other serious illnesses.

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

ATLANTA, Ga. – As Georgia lawmakers reconvene for the 2025 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks forward to working with them to prioritize legislation to ease the burden of cancer on Georgians. The following is a statement from Fabienne Antoine-Nasser , Georgia government relations

NASHVILLE, Tenn. – As Tennessee lawmakers begin the 2025 legislative session Tuesday, the American Cancer Society Cancer Action Network (ACS CAN) urges them to prioritize legislation which would allow more Tennesseans to access biomarker testing, an increasingly important part of cancer care. In the case of a cancer

COLUMBIA, S.C. – As the 2025 legislative session begins Tuesday, the American Cancer Society Cancer Action Network (ACS CAN) urges lawmakers to support policies that will reduce the cancer burden in the Palmetto State. ACS CAN South Carolina Government Relations Director Beth Johnson released the following statement: “We